Home oxygen therapy: evidence versus reality.

Area of Science:

• Respiratory Medicine
• Pulmonary Physiology
• Critical Care

Background:

• Long-term oxygen therapy (LTOT) is a standard treatment for hypoxemic patients.
• Evidence for LTOT benefits primarily stems from 1980s trials in COPD patients, showing survival advantages with ≥15 hours/day use.
• Benefits of LTOT in non-COPD patients remain under-researched, with recommendations often extrapolated from COPD studies.

Purpose of the Study:

• To review the current evidence and guidelines for long-term oxygen therapy (LTOT).
• To assess the continued validity of classic LTOT indications in light of modern treatment and recent trial data.
• To highlight the lack of updated evidence for LTOT in severe hypoxemic patients.

Main Methods:

• Literature research conducted using PubMed.
• Search terms included: LTOT, ambulatory oxygen therapy, short burst oxygen therapy, nocturnal oxygen therapy.
• Focus on home oxygen therapy and its application.

Main Results:

• LTOT demonstrated a survival benefit in COPD patients approximately 30 years ago.
• A recent large trial indicated that COPD patients not meeting classic criteria, with moderate desaturation, do not benefit from oxygen therapy.
• Technical advancements in LTOT devices have improved usability.

Conclusions:

• The long-term survival benefit of LTOT for COPD patients, established decades ago, requires re-evaluation under current treatment paradigms.
• Classic LTOT indications persist in guidelines due to a lack of updated evidence, particularly for severe hypoxemic patients.
• The efficacy of LTOT in non-COPD populations remains largely undetermined.